array(40) {
  [0]=>
  string(4) "2061"
  ["article_id"]=>
  string(4) "2061"
  [1]=>
  string(73) "Coloplast announcement no. 04/2019 - Interim Financial Report, H1 2018/19"
  ["article_title"]=>
  string(73) "Coloplast announcement no. 04/2019 - Interim Financial Report, H1 2018/19"
  [2]=>
  string(132) "H1 2018/19Interim financial report, H1 2018/19(01 October 2018 - 31 March 2019)              "
  ["short_description"]=>
  string(132) "H1 2018/19Interim financial report, H1 2018/19(01 October 2018 - 31 March 2019)              "
  [3]=>
  string(185) "
H1 2018/19

Interim financial report, H1 2018/19
(01 October 2018 - 31 March 2019)              
"
  ["description"]=>
  string(185) "
H1 2018/19

Interim financial report, H1 2018/19
(01 October 2018 - 31 March 2019)              
"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "27"
  ["rss_id"]=>
  string(2) "27"
  [14]=>
  string(140) "http://www.globenewswire.com/news-release/2019/05/02/1814918/0/en/Coloplast-announcement-no-04-2019-Interim-Financial-Report-H1-2018-19.html"
  ["blog_url"]=>
  string(140) "http://www.globenewswire.com/news-release/2019/05/02/1814918/0/en/Coloplast-announcement-no-04-2019-Interim-Financial-Report-H1-2018-19.html"
  [15]=>
  string(19) "2019-05-02 18:09:00"
  ["add_date"]=>
  string(19) "2019-05-02 18:09:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:22"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:22"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2103"
  ["article_id"]=>
  string(4) "2103"
  [1]=>
  string(97) "‘Designer prebiotics’ are the future of food and microbiome modulation, says expert "
  ["article_title"]=>
  string(97) "‘Designer prebiotics’ are the future of food and microbiome modulation, says expert "
  [2]=>
  string(154) "âDesigner prebioticsâ have greater potential than probiotics to be able to modify our microbiomes and improve our long-term health, according to the"
  ["short_description"]=>
  string(154) "âDesigner prebioticsâ have greater potential than probiotics to be able to modify our microbiomes and improve our long-term health, according to the"
  [3]=>
  string(207) "âDesigner prebioticsâ have greater potential than probiotics to be able to modify our microbiomes and improve our long-term health, according to the founder and CEO of a trailblazing life science firm."
  ["description"]=>
  string(207) "âDesigner prebioticsâ have greater potential than probiotics to be able to modify our microbiomes and improve our long-term health, according to the founder and CEO of a trailblazing life science firm."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "35"
  ["rss_id"]=>
  string(2) "35"
  [14]=>
  string(184) "https://www.nutraingredients.com/Article/2019/05/02/Designer-prebiotics-are-the-future-of-food-and-microbiome-modulation-says-expert?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(184) "https://www.nutraingredients.com/Article/2019/05/02/Designer-prebiotics-are-the-future-of-food-and-microbiome-modulation-says-expert?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2019-05-02 17:35:00"
  ["add_date"]=>
  string(19) "2019-05-02 17:35:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:32"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:32"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2210"
  ["article_id"]=>
  string(4) "2210"
  [1]=>
  string(86) "my coworker doesn’t follow her own fragrance ban, my mentor got fired, and more"
  ["article_title"]=>
  string(86) "my coworker doesn’t follow her own fragrance ban, my mentor got fired, and more"
  [2]=>
  string(164) "It’s five answers to five questions. Here we go… 1. My coworker doesn’t follow her own fragrance ban I have a coworker who’s sensitive to "
  ["short_description"]=>
  string(164) "It’s five answers to five questions. Here we go… 1. My coworker doesn’t follow her own fragrance ban I have a coworker who’s sensitive to "
  [3]=>
  string(1708) "
It’s five answers to five questions. Here we go… 1. My coworker doesn’t follow her own fragrance ban I have a coworker who’s sensitive to smells. It’s so bad that our entire office is under a strict “no heavy perfume or scented lotions” rule. The person who’s “sensitive” is so sensitive that she claims to get […]
&#nl
&#nl
You may also like:
&#nl
&#nl
our group member has a fragrance sensitivity – and we’re supposed to be hugged to check for any scents
&#nl
my coworker won’t stop telling me that I smell
&#nl
is it weird to have an essential oil diffuser in my office?
&#nl
&#nl
&#nl
&#nl
my coworker doesn’t follow her own fragrance ban, my mentor got fired, and more was originally published by Alison Green on Ask a Manager.
&#nl"
  ["description"]=>
  string(1708) "
It’s five answers to five questions. Here we go… 1. My coworker doesn’t follow her own fragrance ban I have a coworker who’s sensitive to smells. It’s so bad that our entire office is under a strict “no heavy perfume or scented lotions” rule. The person who’s “sensitive” is so sensitive that she claims to get […]
&#nl
&#nl
You may also like:
&#nl
&#nl
our group member has a fragrance sensitivity – and we’re supposed to be hugged to check for any scents
&#nl
my coworker won’t stop telling me that I smell
&#nl
is it weird to have an essential oil diffuser in my office?
&#nl
&#nl
&#nl
&#nl
my coworker doesn’t follow her own fragrance ban, my mentor got fired, and more was originally published by Alison Green on Ask a Manager.
&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "5"
  ["category"]=>
  string(1) "5"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "50"
  ["rss_id"]=>
  string(2) "50"
  [14]=>
  string(117) "https://www.askamanager.org/2019/05/my-coworker-doesnt-follow-her-own-fragrance-ban-my-mentor-got-fired-and-more.html"
  ["blog_url"]=>
  string(117) "https://www.askamanager.org/2019/05/my-coworker-doesnt-follow-her-own-fragrance-ban-my-mentor-got-fired-and-more.html"
  [15]=>
  string(19) "2019-05-02 12:03:14"
  ["add_date"]=>
  string(19) "2019-05-02 12:03:14"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:44"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:44"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1924"
  ["article_id"]=>
  string(4) "1924"
  [1]=>
  string(175) "Agios Announces FDA Approval of Tibsovo as Monotherapy for Newly Diagnosed Adult Patients with IDH1 Mutant Acute Myeloid Leukemia (AML) Not Eligible for Intensive Chemotherapy"
  ["article_title"]=>
  string(175) "Agios Announces FDA Approval of Tibsovo as Monotherapy for Newly Diagnosed Adult Patients with IDH1 Mutant Acute Myeloid Leukemia (AML) Not Eligible for Intensive Chemotherapy"
  [2]=>
  string(150) "CAMBRIDGE, Mass., May 02, 2019 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc., a leader in the field of cellular metabolism to treat cancer and rare "
  ["short_description"]=>
  string(150) "CAMBRIDGE, Mass., May 02, 2019 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc., a leader in the field of cellular metabolism to treat cancer and rare "
  [3]=>
  string(241) "CAMBRIDGE, Mass., May 02, 2019 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc., a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced the U.S. Food and Drug Administration (FDA) approved a..."
  ["description"]=>
  string(241) "CAMBRIDGE, Mass., May 02, 2019 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc., a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced the U.S. Food and Drug Administration (FDA) approved a..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "8"
  ["rss_id"]=>
  string(1) "8"
  [14]=>
  string(300) "https://www.drugs.com/newdrugs/agios-announces-fda-approval-tibsovo-monotherapy-newly-diagnosed-adult-patients-idh1-mutant-acute-4965.html?utm_source=ddc&utm_medium=rss&utm_campaign=Agios+Announces+FDA+Approval+of+Tibsovo+as+Monotherapy+for+Newly+Diagnosed+Adult+Patients+with+IDH1+Mutant+Acute+Myelo"
  ["blog_url"]=>
  string(300) "https://www.drugs.com/newdrugs/agios-announces-fda-approval-tibsovo-monotherapy-newly-diagnosed-adult-patients-idh1-mutant-acute-4965.html?utm_source=ddc&utm_medium=rss&utm_campaign=Agios+Announces+FDA+Approval+of+Tibsovo+as+Monotherapy+for+Newly+Diagnosed+Adult+Patients+with+IDH1+Mutant+Acute+Myelo"
  [15]=>
  string(19) "2019-05-02 09:05:18"
  ["add_date"]=>
  string(19) "2019-05-02 09:05:18"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:35:50"
  ["create_at"]=>
  string(19) "2019-05-09 16:35:50"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1988"
  ["article_id"]=>
  string(4) "1988"
  [1]=>
  string(210) "Celgene Corporation and bluebird bio Announce Results from Ongoing Multicenter Phase 1 Study of bb2121 anti-BCMA CAR T Cell Therapy in Patients with Multiple Myeloma Published in New England Journal of Medicine"
  ["article_title"]=>
  string(210) "Celgene Corporation and bluebird bio Announce Results from Ongoing Multicenter Phase 1 Study of bb2121 anti-BCMA CAR T Cell Therapy in Patients with Multiple Myeloma Published in New England Journal of Medicine"
  [2]=>
  string(150) "SUMMIT, N.J. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 01, 2019 -- Celgene Corporation (Nasdaq: CELG) and bluebird bio, Inc. (Nasdaq: BLUE) today a"
  ["short_description"]=>
  string(150) "SUMMIT, N.J. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 01, 2019 -- Celgene Corporation (Nasdaq: CELG) and bluebird bio, Inc. (Nasdaq: BLUE) today a"
  [3]=>
  string(244) "SUMMIT, N.J. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 01, 2019 -- Celgene Corporation (Nasdaq: CELG) and bluebird bio, Inc. (Nasdaq: BLUE) today announced that the New England Journal of Medicine (NEJM) has published interim results from..."
  ["description"]=>
  string(244) "SUMMIT, N.J. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 01, 2019 -- Celgene Corporation (Nasdaq: CELG) and bluebird bio, Inc. (Nasdaq: BLUE) today announced that the New England Journal of Medicine (NEJM) has published interim results from..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "15"
  ["rss_id"]=>
  string(2) "15"
  [14]=>
  string(300) "https://www.drugs.com/clinical_trials/celgene-corporation-bluebird-bio-announce-results-ongoing-multicenter-phase-1-study-bb2121-anti-18132.html?utm_source=ddc&utm_medium=rss&utm_campaign=Celgene+Corporation+and+bluebird+bio+Announce+Results+from+Ongoing+Multicenter+Phase+1+Study+of+bb2121+anti-BCMA"
  ["blog_url"]=>
  string(300) "https://www.drugs.com/clinical_trials/celgene-corporation-bluebird-bio-announce-results-ongoing-multicenter-phase-1-study-bb2121-anti-18132.html?utm_source=ddc&utm_medium=rss&utm_campaign=Celgene+Corporation+and+bluebird+bio+Announce+Results+from+Ongoing+Multicenter+Phase+1+Study+of+bb2121+anti-BCMA"
  [15]=>
  string(19) "2019-05-02 07:05:46"
  ["add_date"]=>
  string(19) "2019-05-02 07:05:46"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:35:57"
  ["create_at"]=>
  string(19) "2019-05-09 16:35:57"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2121"
  ["article_id"]=>
  string(4) "2121"
  [1]=>
  string(64) "Repare Therapeutics Appoints Maria Koehler Chief Medical Officer"
  ["article_title"]=>
  string(64) "Repare Therapeutics Appoints Maria Koehler Chief Medical Officer"
  [2]=>
  string(150) "Maria Koehler has been appointed executive vice president and chief medical officer of Repare Therapeutics. Koehler comes to Repare from Bicycle Thera"
  ["short_description"]=>
  string(150) "Maria Koehler has been appointed executive vice president and chief medical officer of Repare Therapeutics. Koehler comes to Repare from Bicycle Thera"
  [3]=>
  string(380) "Maria Koehler has been appointed executive vice president and chief medical officer of Repare Therapeutics. Koehler comes to Repare from Bicycle Therapeutics, where she was CMO. Her experience also includes senior roles at Pfizer (NYSE: PFE). In other moves, former Avrobio chief financial officer Katrina Dorton was appointed executive vice president and CFO of Repare. […]"
  ["description"]=>
  string(380) "Maria Koehler has been appointed executive vice president and chief medical officer of Repare Therapeutics. Koehler comes to Repare from Bicycle Therapeutics, where she was CMO. Her experience also includes senior roles at Pfizer (NYSE: PFE). In other moves, former Avrobio chief financial officer Katrina Dorton was appointed executive vice president and CFO of Repare. […]"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "36"
  ["rss_id"]=>
  string(2) "36"
  [14]=>
  string(103) "https://xconomy.com/boston/2019/05/01/repare-therapeutics-appoints-maria-koehler-chief-medical-officer/"
  ["blog_url"]=>
  string(103) "https://xconomy.com/boston/2019/05/01/repare-therapeutics-appoints-maria-koehler-chief-medical-officer/"
  [15]=>
  string(19) "2019-05-01 21:43:24"
  ["add_date"]=>
  string(19) "2019-05-01 21:43:24"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:33"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:33"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1961"
  ["article_id"]=>
  string(4) "1961"
  [1]=>
  string(100) "Guidance published on sharing prescribing data between pharmacists and GPs to improve patient safety"
  ["article_title"]=>
  string(100) "Guidance published on sharing prescribing data between pharmacists and GPs to improve patient safety"
  [2]=>
  string(150) "Guidance on how to share patient prescribing data in a standardised format to improve communications between healthcare professionals should result in"
  ["short_description"]=>
  string(150) "Guidance on how to share patient prescribing data in a standardised format to improve communications between healthcare professionals should result in"
  [3]=>
  string(214) "Guidance on how to share patient prescribing data in a standardised format to improve communications between healthcare professionals should result in better patient safety, according to the body that published it."
  ["description"]=>
  string(214) "Guidance on how to share patient prescribing data in a standardised format to improve communications between healthcare professionals should result in better patient safety, according to the body that published it."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "11"
  ["rss_id"]=>
  string(2) "11"
  [14]=>
  string(188) "https://www.pharmaceutical-journal.com/news-and-analysis/news-in-brief/guidance-published-on-sharing-prescribing-data-between-pharmacists-and-gps-to-improve-patient-safety/20206493.article"
  ["blog_url"]=>
  string(188) "https://www.pharmaceutical-journal.com/news-and-analysis/news-in-brief/guidance-published-on-sharing-prescribing-data-between-pharmacists-and-gps-to-improve-patient-safety/20206493.article"
  [15]=>
  string(19) "2019-05-01 21:34:00"
  ["add_date"]=>
  string(19) "2019-05-01 21:34:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:35:53"
  ["create_at"]=>
  string(19) "2019-05-09 16:35:53"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2203"
  ["article_id"]=>
  string(4) "2203"
  [1]=>
  string(126) "Pharma’s dependence on legal departments, CROs to blame? ‘Common sense is completely gone out of research’"
  ["article_title"]=>
  string(126) "Pharma’s dependence on legal departments, CROs to blame? ‘Common sense is completely gone out of research’"
  [2]=>
  string(150) "Clinical trials are less safe today as researchers are inundated with increasing amounts of data and new processes developed in part by CROs, which ha"
  ["short_description"]=>
  string(150) "Clinical trials are less safe today as researchers are inundated with increasing amounts of data and new processes developed in part by CROs, which ha"
  [3]=>
  string(287) "Clinical trials are less safe today as researchers are inundated with increasing amounts of data and new processes developed in part by CROs, which have created âtier upon tier of bureaucracy,â argues industry expert, who warns that things are getting âmore and more stupid.â"
  ["description"]=>
  string(287) "Clinical trials are less safe today as researchers are inundated with increasing amounts of data and new processes developed in part by CROs, which have created âtier upon tier of bureaucracy,â argues industry expert, who warns that things are getting âmore and more stupid.â"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "49"
  ["rss_id"]=>
  string(2) "49"
  [14]=>
  string(208) "https://www.outsourcing-pharma.com/Article/2019/05/01/Pharma-s-dependence-on-legal-departments-CROs-to-blame-Common-sense-is-completely-gone-out-of-research?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(208) "https://www.outsourcing-pharma.com/Article/2019/05/01/Pharma-s-dependence-on-legal-departments-CROs-to-blame-Common-sense-is-completely-gone-out-of-research?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2019-05-01 20:36:00"
  ["add_date"]=>
  string(19) "2019-05-01 20:36:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:44"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:44"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2351"
  ["article_id"]=>
  string(4) "2351"
  [1]=>
  string(97) "Smith & Nephew Adopts One-platform Approach with Medidata to Support Expansion of Study Portfolio"
  ["article_title"]=>
  string(97) "Smith & Nephew Adopts One-platform Approach with Medidata to Support Expansion of Study Portfolio"
  [2]=>
  string(150) "Medical technology company consolidates study management on the Medidata Rave® Clinical Cloud™By using a consolidated platform, data flows "
  ["short_description"]=>
  string(150) "Medical technology company consolidates study management on the Medidata Rave® Clinical Cloud™By using a consolidated platform, data flows "
  [3]=>
  string(582) "Medical technology company consolidates study management on the Medidata Rave® Clinical Cloud™By using a consolidated platform, data flows seamlessly between electronic data capture (EDC) and clinical trial management system (CTMS) solutionsClinical operations teams can focus on critical study oversight activities rather than data collection and integrationLondon, UK: 1st May 2019 - Medidata (NASDAQ: MDSO) today announced that medical technology business Smith & Nephew (LSE: SN, NYSE: SNN) has consolidated all of its global studies on...&#nl&#nlSource: RealWire"
  ["description"]=>
  string(582) "Medical technology company consolidates study management on the Medidata Rave® Clinical Cloud™By using a consolidated platform, data flows seamlessly between electronic data capture (EDC) and clinical trial management system (CTMS) solutionsClinical operations teams can focus on critical study oversight activities rather than data collection and integrationLondon, UK: 1st May 2019 - Medidata (NASDAQ: MDSO) today announced that medical technology business Smith & Nephew (LSE: SN, NYSE: SNN) has consolidated all of its global studies on...&#nl&#nlSource: RealWire"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "64"
  ["rss_id"]=>
  string(2) "64"
  [14]=>
  string(88) "http://www.realwire.com/releases/Smith-Nephew-Adopts-One-platform-Approach-with-Medidata"
  ["blog_url"]=>
  string(88) "http://www.realwire.com/releases/Smith-Nephew-Adopts-One-platform-Approach-with-Medidata"
  [15]=>
  string(19) "2019-05-01 20:30:00"
  ["add_date"]=>
  string(19) "2019-05-01 20:30:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:42:04"
  ["create_at"]=>
  string(19) "2019-05-09 16:42:04"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2122"
  ["article_id"]=>
  string(4) "2122"
  [1]=>
  string(63) "Meet the Xconomy Awards San Diego Digital Trailblazer Finalists"
  ["article_title"]=>
  string(63) "Meet the Xconomy Awards San Diego Digital Trailblazer Finalists"
  [2]=>
  string(150) "San Diego’s prowess in computer science, medical devices, and life sciences makes it a natural hub of innovative digital health companies. The f"
  ["short_description"]=>
  string(150) "San Diego’s prowess in computer science, medical devices, and life sciences makes it a natural hub of innovative digital health companies. The f"
  [3]=>
  string(380) "San Diego’s prowess in computer science, medical devices, and life sciences makes it a natural hub of innovative digital health companies. The finalists in the Digital Trailblazer category of the Xconomy Awards San Diego highlight the wide variety of healthtech ideas emanating from local startups and big companies alike, ranging from virtual coaches for physical […]"
  ["description"]=>
  string(380) "San Diego’s prowess in computer science, medical devices, and life sciences makes it a natural hub of innovative digital health companies. The finalists in the Digital Trailblazer category of the Xconomy Awards San Diego highlight the wide variety of healthtech ideas emanating from local startups and big companies alike, ranging from virtual coaches for physical […]"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "37"
  ["rss_id"]=>
  string(2) "37"
  [14]=>
  string(62) "http://feedproxy.google.com/~r/XconomyHealthIT/~3/V6t7-7OGE2s/"
  ["blog_url"]=>
  string(62) "http://feedproxy.google.com/~r/XconomyHealthIT/~3/V6t7-7OGE2s/"
  [15]=>
  string(19) "2019-05-01 19:56:11"
  ["add_date"]=>
  string(19) "2019-05-01 19:56:11"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:33"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:33"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2377"
  ["article_id"]=>
  string(4) "2377"
  [1]=>
  string(66) "U.S. Healthcare Market Continues to be Major Target for Hackers"
  ["article_title"]=>
  string(66) "U.S. Healthcare Market Continues to be Major Target for Hackers"
  [2]=>
  string(153) "A recent report from Frost & Sullivan anticipates strong market growth but also points to opportunity for more vulnerabilities.&#nlThe post U.S. Hea"
  ["short_description"]=>
  string(153) "A recent report from Frost & Sullivan anticipates strong market growth but also points to opportunity for more vulnerabilities.&#nlThe post U.S. Hea"
  [3]=>
  string(510) "
A recent report from Frost & Sullivan anticipates strong market growth but also points to opportunity for more vulnerabilities.
&#nl
The post U.S. Healthcare Market Continues to be Major Target for Hackers appeared first on MedTech Intelligence.
&#nl"
  ["description"]=>
  string(510) "
A recent report from Frost & Sullivan anticipates strong market growth but also points to opportunity for more vulnerabilities.
&#nl
The post U.S. Healthcare Market Continues to be Major Target for Hackers appeared first on MedTech Intelligence.
&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "98"
  ["rss_id"]=>
  string(2) "98"
  [14]=>
  string(112) "https://www.medtechintelligence.com/news_article/u-s-healthcare-market-continues-to-be-major-target-for-hackers/"
  ["blog_url"]=>
  string(112) "https://www.medtechintelligence.com/news_article/u-s-healthcare-market-continues-to-be-major-target-for-hackers/"
  [15]=>
  string(19) "2019-05-01 19:22:39"
  ["add_date"]=>
  string(19) "2019-05-01 19:22:39"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:42:22"
  ["create_at"]=>
  string(19) "2019-05-09 16:42:22"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "4542"
  ["article_id"]=>
  string(4) "4542"
  [1]=>
  string(37) "Risk Management for Clinical Research"
  ["article_title"]=>
  string(37) "Risk Management for Clinical Research"
  [2]=>
  string(150) "Risk management is becoming increasingly important to running clinical trials and ensuring compliance with regulatory expectations. There are now nume"
  ["short_description"]=>
  string(150) "Risk management is becoming increasingly important to running clinical trials and ensuring compliance with regulatory expectations. There are now nume"
  [3]=>
  string(506) "Risk management is becoming increasingly important to running clinical trials and ensuring compliance with regulatory expectations. There are now numerous pharmaceutical guidelines covering risk management including ICH Q9 and the revised ICH GCP R2 guideline.&#nl&#nlThis essential one-day course will explain the importance of using risk management techniques in clinical research to comply with the latest focus on inspection in this area. It will show you how risk management can improve the quality..."
  ["description"]=>
  string(506) "Risk management is becoming increasingly important to running clinical trials and ensuring compliance with regulatory expectations. There are now numerous pharmaceutical guidelines covering risk management including ICH Q9 and the revised ICH GCP R2 guideline.&#nl&#nlThis essential one-day course will explain the importance of using risk management techniques in clinical research to comply with the latest focus on inspection in this area. It will show you how risk management can improve the quality..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(69) "https://www.pharmiweb.com/event/risk-management-for-clinical-research"
  ["blog_url"]=>
  string(69) "https://www.pharmiweb.com/event/risk-management-for-clinical-research"
  [15]=>
  string(19) "2019-05-01 17:57:12"
  ["add_date"]=>
  string(19) "2019-05-01 17:57:12"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-09-14 14:32:21"
  ["create_at"]=>
  string(19) "2019-09-14 14:32:21"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}